Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
31 January 2018 Photo UFS Archive
Young squad did it for Shimlas
The 11th season of this popular rugby competition started on Monday 29 January, with the scoreboard favouring Shimlas on 19 points versus the 17 points of Tuks.

The head coach of the Shimla rugby team is confident that the skills level of the players will stand them in good stead for the upcoming Varsity Cup.

The 11th season of this popular rugby competition started on Monday 29 January, with the scoreboard favouring Shimlas on 19 points versus the 17 points of Tuks. The Shimlas faced last year’s champions, Tuks, in Pretoria. 

The rest of the 2018 Varsity Cup season will have the Shimlas playing on 5 February against Maties (away); 12 February against Wits (home); 19 February against Ikeys (away); 26 February against UJ (home); 12 March against NWU (away); 19 March against Madibaz (home); and 26 March against CUT (home).

Head coach, Hendro Scholtz, believes his players have the ability to play at a high tempo for 80 minutes.

“We don’t have the biggest boys around, so we rely on our speed and ability to throw the ball around. You can focus on your defence as much as you like, but tries will be scored. You simply have to ensure that you outscore your opponents,” said Hendro.

With up to nine players from last year’s squad not available again in 2018, the Shimlas are entering the competition with a very young and inexperienced team. According to Hendro, the big dropout since last year is due to a number of reasons, such as students who finished their studies.

“We will have to battle this Varsity Cup with a very young team, of which 10 players were still U19 last year. We faced the University of Johannesburg in a warm-up match, and for many of them it was an eye-opener. The speed and intensity is at a higher level than they were used to at U19 level,” said Hendro, a former Shimla himself.

He will be assisted by Melusi Mthetwa and Jaco Swanepoel.

* The Shimla squad:
Backs: Sango Xamlashe, Carel-Jan Coetzee, Kurt Eybers, Dian Badenhorst, Frank van Heerden, Francois Agenbach, Arrie Pretorius, Rewan Kruger, Zinedine Booysen, Nakkie Naudé, Lubabalo Dobela, William Eybers, Francois Pretorius, Aya Oliphant, Charl Pretorius, Ruan Henning, Sechaba Matsoele, Athi Halom, Jarik van der Walt, Tiaan Schutte, Marnus Boshoff. Forwards: Johan Kotze (captain), Louis Cloete, Nardus Erasmus, JC Janse van Vuuren, Ruan Roelofse, Magau Mabokela, Jano Botha, Helgard Meyer, Wentzel Vorster, Hanno Snyman, Marco van der Merwe, Merwyn Roos, Raymond Woest, Sibabalo Qoma, Nathan Jordan, Benji Jan van Vuuren, Menzi Nhlabathi, Janco Cloete, Kobus Lombaard, Bertie de Bod, Rholane Ncubuka, Henk Pretorius.

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 
Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept